Organic Active Ingredients TRIZ Cases

Arylsulfonyl-substituted oxindole compounds achieve selective V1b receptor binding while avoiding off-target interactions with V1a and oxytocin receptors.

Vacuolin-1 blocks autophagosome-lysosome fusion to resolve the toxicity trade-off of conventional inhibitors like chloroquine.

Formula I compounds block NaV1.7 sodium channels to reduce ion flux, resolving the trade-off between therapeutic index and side effects.

Deuterium-substituted morphinan analogs maintain pain relief while reducing euphoria and respiratory depression via parameter changes in molecular structure.

Radial elements collapse inward after hardening to enable tendon access and reuse, resolving single-use waste.

Segmented tetracyclic compounds inhibit autotaxin to treat cancer and fibrosis by blocking the ATX-LPA signaling pathway.

Dimeric Smac mimetics displace caspases from inhibitor of apoptosis proteins, overcoming treatment resistance and enabling effective cancer therapy.

A chiral Ru(II) catalyst enables asymmetric synthesis of difluoropiperidine intermediates with high enantiomeric excess.

Co-administering Vitamin D3, heat shock proteins, and glutathione reduces chronic inflammation.

Specific piperazine substitution patterns enhance D3 receptor selectivity, reducing side effects while maintaining therapeutic efficacy.

A bivalent compound links a Bcl-2 inhibitor to an E3 ligase moiety via a cleavable linker.

Automated transfer module moves liquid medication between drug and dose chambers to enable precise volume measurement.

Arabinoxylan promotes Blautia obeum abundance in infant gut microbiota, reducing diarrhea by addressing underlying microbiome imbalance.

Segmented gapmer structures reduce WFDC2 levels, addressing limited prior art on therapeutic efficacy.

Tapioca maltodextrin absorbs lipid concentrates into a stable powder, eliminating microbial risks and enabling rapid cannabinoid absorption without cooking.

A plasmalogen composition uses gamma-cyclodextrin to form a protective inclusion complex.

Schiff base condensation creates voriconazole hydrogel to increase drug permeability and retention time on the ocular surface.

3-Aza-bicyclo[3.2.1]octane compounds activate ADAR1 to modulate inflammatory responses.

Direct compression avoids thermal degradation to improve storage stability and reduce impurity formation.

A synergistic phytoextract formulation combines cardamom, rosemary, and piperine to deliver anti-inflammatory and analgesic effects via 1,8 Cineol.

Crystalline form VI of agomelatine forms through controlled phase transitions, resolving reproducibility issues and ensuring stable pharmaceutical compositions.

Lithium ascorbate prevents irreversible neural damage by inhibiting lipid peroxidation and normalizing biochemical reactions.

A composition combines hyaluronic acid with Manuka-derived products to counteract bacterial hyaluronidases that depolymerize the polysaccharide.

siRNA molecules in lipid particles silence Marburg virus genes, reducing viral load by 50% against resistant Angola strains.

Composite mixtures of novel organic selenides and DPPD reduce oxidative stress markers to treat breast cancer progression.

Compounds activate MEF2 transcriptional activity to address deficits in MEF2C activity found in autism spectrum disorder and neurodegenerative diseases.

Gaseous oxygen eliminates anaerobic pathogens while hyaluronic acid protects beneficial bacteria, treating infertility without invasive procedures.

Dual-function cationic lipids combine polyanionic interactions with basic amino acid sequences to transfect suspension cells without complex formulations.

A biodegradable adhesive composition reacts isocyanate and active hydrogen components to bond biological tissues at body temperature.

Lumichrome addresses inadequate NAFLD treatments by reducing liver enzymes and visceral fat without adverse effects.

A biocompatible matrix coating delivers cancer-fighting drugs via slow release to the bladder wall.

Applies tumor treating fields alongside DNA-PK inhibitors to block nonhomologous end joining repair pathways, increasing radiation therapy efficacy.

Indole derivatives inhibit ferroptosis by reducing oxidative stress and lipid peroxidation, addressing the lack of non-toxic inhibitors.

Indazole ureas selectively block Nav1.7 and Nav1.8 channels, resolving the trade-off between potency and therapeutic index in pain treatment.

Hexadecahydro-1H-cyclopenta[a]phenanthrene derivatives modulate immune cell activation and nociceptor sensitization.

Attenuated cancer cells expressing herd-immunized antigens convert immunologically cold tumors into hot phenotypes for enhanced T-cell infiltration.

A vitamin supplement composition combines specific B6, B9, and B12 derivatives to improve nutrient bioavailability through synergistic interactions.

Targeting SIRPgamma on cancer stem cells removes resistance mechanisms that block chemotherapy, enabling effective immune-mediated tumor growth control.

Composite molecule combines ataluren and HMB to improve bioavailability and treat muscular dystrophy.

A trisubstituted amine compound inhibits cholesteryl ester transfer protein activity to modulate lipid levels.

Parabacteroides distasonis and bile acids regulate lipid metabolism to reduce body fat percentage, increasing slaughter weight without veterinary drug residues.

A strontium-based composition delivers systemic bone strengthening and dental remineralization through oral administration.

A solid pharmaceutical composition combines azetidin-3-ol with mannitol and croscarmellose sodium to produce stable tablets.

A compacted intermediate form of BIBW 2992 dimaleate salt improves powder flowability and compressibility for solid oral formulations.